TNF and tuberculosis: The risk of reactivation of tuberculosis by TNF inhibitors is a generally recognized consequence of this type of treatment and may limit the use of these drugs, particularly in countries where tuberculosis is endemic or in people with a history of tuberculosis [8,9].